Skip to main content

Table 4 Summary of the changes of waist circumference, systolic and diastolic blood pressure, fasting plasma glucose, triglycerides, high density lipoprotein cholesterol (HDL-C), heart rate, and International Physical Activity Question (IPAQ) activity and sitting levels at baseline (Pre), midway (Mid), and completion (Post) of the 1-year experimental period in Control and Yoga groups

From: Effects of 1-year yoga on cardiovascular risk factors in middle-aged and older adults with metabolic syndrome: a randomized trial

 

Control group (n=98 for PP, n=137 for ITT)

Yoga group (n=84 for PP, n=146 for ITT)

 
 

Pre

Mid

Post

Pre

Mid

Post

P-value (PP)

Effect size (PP)

P-value (ITT)

Effect size (ITT)

Waist circumference (cm)

89.2 ± 6.3

87.4 ± 7.0

89.5 ± 7.6

89.9 ± 7.7

87.78 ± 8.3

86.8 ± 6.9

0.003#

0.010

0.041#

0.005

0.024##

0.027

0.001##

0.019

Systolic pressure (mmHg)

132.8 ± 17.8

131.5 ± 17.0

130.2 ± 18.1

135.0 ± 15.5

129.1 ± 13.8

128.5 ± 13.8

0.067

0.021

0.001##

0.019

Diastolic pressure (mmHg)

81.3 ± 10.5

80.4 ± 9.8

79.7 ± 10.1

83.6 ± 9.0

79.8 ± 9.6

80.0 ± 10.4

0.107

0.019

0.001###

0.012

Fasting plasma glucose (mmol/L)

5.8 ± 1.0

5.6 ± 0.9

5.6 ± 1.2

5.7 ± 1.3

5.6 ± 1.4

5.5 ± 1.4

0.567

0.004

0.026###

0.002

Fasting plasma triglycerides (mmol/L)

2.4 ± 2.2

2.3 ± 2.1

2.1 ± 1.2

2.0 ± 1.0

2.0 ± 1.3

1.8 ± 0.7

0.891

0.007

0.007###

0.009

Fasting plasma HDL-C (mmol/L)

1.2 ± 0.3

1.2 ± 0.3

1.2 ± 0.3

1.2 ± 0.2

1.2 ± 0.2

1.2 ± 0.2

0.567

0.003

0.031###

0.003

Resting heart rate (beats/min)

71.0 ± 8.6

71.3 ± 10.8

71.0 ± 10.7

71.2 ± 10.0

70.9 ± 8.3

67.8 ± 7.5

0.039#

0.006

0.016###

0.003

0.001##

0.011

0.005

IPAQ activity (MET-minutes/week)

2857.6 ± 4953.4

2607.8 ± 2064.3

3386.6 ± 3745.9

3629.8 ± 2735.7

3608.9 ± 4223.0

3977.7 ± 3946.4

0.051

0.009

0.001###

0.021

IPAQ sitting (minutes/week)

2291.6 ± 1494.5

2101.1 ± 1479.7

1973.0 ± 1517.8

2485.2 ± 1563.3

2256.1 ± 1223.6

2233.3 ± 1274.7

0.004###

0.014

0.044###

0.009

SF-12-PCS

46.64 ± 6.99

47.01 ± 7.98

47.00 ± 8.21

44.06 ± 8.02

47.21 ± 7.54

47.20 ± 7.94

0.031###

0.010

0.039###

0.015

SF-12-MCS

52.30 ± 8.16

51.21 ± 8.30

52.09 ±6.80

50.58 ± 8.84

51.01 ± 8.97

51.76 ±8.70

0.268

0.003

0.073

0.005

CES-D

11.62 ± 7.23

11.77 ± 6.58

10.47 ± 6.64

12.58 ± 7.86

11.85 ± 7.37

12.38 ± 8.53

0.179

0.001

0.631

0.001

  1. #Significant interaction effect existed between yoga intervention and time, ##Significant interaction effect existed between the change in IPAQ activity and time according to our mixed design repeated measure analysis of co-variance (ANCOVA) with a 2 × 3 (Change in IPAQ × time) model. ###Significant main effect of time existed according to our mixed design repeated measure analysis of variance (ANOVA) with a 2 × 3 (yoga intervention × time) model. PP; per protocol analysis, ITT; intention-to-treat analysis.